Seller comparison · US self-pay prices

LifeRx.md vs MEDVi: LifeRx.md Is Cheaper, GLP-1 Prices Compared

Last updated

Each seller's lowest price now

  • Lowest price, compounded and not FDA-approved

    LifeRx.md

    $147/mo

  • Lowest price, compounded and not FDA-approved

    MEDVi

    $199/mo

The same medicine for less than LifeRx.md and MEDVi, at sellers we link to

  • Compounded semaglutide, not FDA-approved

    Eden

    $99/mo · about $51 less per 30 days than LifeRx.md

  • Compounded tirzepatide, not FDA-approved

    Eden

    $129/mo · about $73 less per 30 days than LifeRx.md

They pay us if you buy, which never changes a price we show.

LifeRx.md and MEDVi both sell compounded semaglutide injection and compounded tirzepatide injection. Compounded semaglutide injection: about $52 a month less at LifeRx.md (about $624 over a year): $147/mo, against $199/mo at MEDVi. Compounded tirzepatide injection: about $109 less per 30 days at LifeRx.md: $197/mo (≈ $211 per 30 days, its month read as four weekly doses), against ≈ $320 per 30 days at MEDVi. Both list only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. Prices checked Nov 11, 2026 and Nov 13, 2026.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Same product

What LifeRx.md and MEDVi charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price names the seller's own page it was read from.

Compounded semaglutide injection

Entry price: about $52 a month less at LifeRx.md (about $624 over a year): $147/mo, against $199/mo at MEDVi. Top dose: only LifeRx.md publishes a top-dose price here: $147/mo at 2.4 mg.

LifeRx.md

Advertised entry price

$147/mo (liferx.md/weight-loss)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on liferx.md

Compounded semaglutide via LifeRx.md

LifeRx.md · seller's own price

"Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "No membership fees ($0)" and "No auto-billing"

Price conditions

"Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "No membership fees ($0)" and "No auto-billing"

Refills are requested when you are ready ("We never auto-bill."). Pricing, eligibility and other terms apply per the page. Compounded; not FDA-approved.

Published maintenance dose

$147/mo (liferx.md/weight-loss)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on liferx.md

At 2.4 mg

Compounded semaglutide via LifeRx.md

LifeRx.md · seller's own price

"Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "No membership fees ($0)" and "No auto-billing"

Price conditions

"Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "No membership fees ($0)" and "No auto-billing"

Refills are requested when you are ready ("We never auto-bill."). Pricing, eligibility and other terms apply per the page. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 2.4 mg.

MEDVi

Advertised entry price

$199/mo (glp1.medvi.org)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on glp1.medvi.org

Compounded semaglutide via MEDVi

MEDVi · seller's own price

refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

Price conditions

refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

Published maintenance dose

No dose-specific quote tracked.

Compounded tirzepatide injection

Entry price: about $109 less per 30 days at LifeRx.md: $197/mo (≈ $211 per 30 days, its month read as four weekly doses), against ≈ $320 per 30 days at MEDVi. Top dose: about $109 less per 30 days at LifeRx.md: $197/mo at 15 mg (≈ $211 per 30 days, its month read as four weekly doses), against ≈ $320 per 30 days at 15 mg at MEDVi.

LifeRx.md

Advertised entry price

$197/mo (liferx.md/weight-loss)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on liferx.md

Compounded tirzepatide via LifeRx.md

LifeRx.md · seller's own price

"Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "Your price stays the same as your dose changes" and "No auto-billing"

Price conditions

"Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "Your price stays the same as your dose changes" and "No auto-billing"

Refills are requested when you are ready ("We never auto-bill."). Pricing, eligibility and other terms apply per the page. Compounded; not FDA-approved.

Published maintenance dose

$197/mo (liferx.md/weight-loss)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on liferx.md

At 15 mg

Compounded tirzepatide via LifeRx.md

LifeRx.md · seller's own price

"Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "Your price stays the same as your dose changes" and "No auto-billing"

Price conditions

"Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "Your price stays the same as your dose changes" and "No auto-billing"

Refills are requested when you are ready ("We never auto-bill."). Pricing, eligibility and other terms apply per the page. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 15 mg.

MEDVi

Advertised entry price

$299/mo (glp1.medvi.org/results/cv-tirz)

28-day supply (glp1.medvi.org)

≈ $320.36 per 30 days at this quoted rate

Checked on glp1.medvi.org

Compounded tirzepatide via MEDVi

MEDVi · seller's own price

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

Price conditions

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

28-day supply

Published maintenance dose

$299/mo (glp1.medvi.org/results/cv-tirz)

28-day supply (glp1.medvi.org)

≈ $320.36 per 30 days at this quoted rate

Checked on glp1.medvi.org

At 15 mg

Compounded tirzepatide via MEDVi

MEDVi · seller's own price

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

Price conditions

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 15 mg.

28-day supply

Same medication, lower price

Cheaper than LifeRx.md and MEDVi

Other sellers' current prices for the same product, below the lower of these two, compared per 30 days where both state their supply. Compounded medication is compared only with compounded, and an FDA-approved product only with itself.

Compounded, not FDA-approved

Compounded semaglutide

Lower than both. LifeRx.md: $147/mo, checked Nov 13, 2026 on liferx.md.

  1. Collective: $59/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. Sunlight: $78/mo, about $84 per 30 days. Checked Nov 11, 2026 on sunlight.com.View offer
  3. Avono Health: $79/mo. Checked Nov 13, 2026 on avonohealth.com.View offer
  4. Embody: $79/mo. Checked Nov 14, 2026 on joinem.co.View offer

Compounded, not FDA-approved

Compounded tirzepatide

Lower than both. LifeRx.md: $197/mo, checked Nov 13, 2026 on liferx.md.

  1. Collective: $69/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. FlatRx: $118/mo. Checked Nov 17, 2026 on flatrx.io.View offer
  3. Arbor: $119/mo. Checked Nov 13, 2026 on startarbor.com.View offer
  4. Mint Med: $119/mo. Checked Nov 11, 2026 on mintmed.com.View offer

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss (fda.gov)

Questions

LifeRx.md vs MEDVi: common questions

Is LifeRx.md or MEDVi cheaper for GLP-1 medication?

Compounded semaglutide injection: about $52 a month less at LifeRx.md (about $624 over a year): $147/mo, against $199/mo at MEDVi. At the top published dose, only LifeRx.md publishes a top-dose price here: $147/mo at 2.4 mg. Compounded tirzepatide injection: about $109 less per 30 days at LifeRx.md: $197/mo (≈ $211 per 30 days, its month read as four weekly doses), against ≈ $320 per 30 days at MEDVi. At the top published dose, about $109 less per 30 days at LifeRx.md: $197/mo at 15 mg (≈ $211 per 30 days, its month read as four weekly doses), against ≈ $320 per 30 days at 15 mg at MEDVi. Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do LifeRx.md and MEDVi sell FDA-approved GLP-1s or compounded versions?

Both list only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do LifeRx.md and MEDVi prices include?

LifeRx.md, compounded semaglutide injection: $147/mo, "Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "No membership fees ($0)" and "No auto-billing". MEDVi, compounded semaglutide injection: $199/mo, refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract. LifeRx.md, compounded tirzepatide injection: $197/mo, "Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "Your price stays the same as your dose changes" and "No auto-billing". MEDVi, compounded tirzepatide injection: $299/mo, monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months).

When were LifeRx.md and MEDVi prices last checked?

Prices checked Nov 11, 2026 and Nov 13, 2026. Each quote names the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Every sourced offer

All LifeRx.md and MEDVi offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

4 current prices

Lowest starting 30-day cost ·

  • View
    $147/mo (liferx.md/weight-loss)

    Checked on liferx.md

    Top dose: same price at 2.4 mg

    Terms & source

    Advertised price: "Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "No membership fees ($0)" and "No auto-billing"

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Top-dose terms: The seller states one price at every dose, so this is also its price at 2.4 mg.

    Refills are requested when you are ready ("We never auto-bill."). Pricing, eligibility and other terms apply per the page. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (liferx.md)
  • View
    $197/mo (liferx.md/weight-loss)

    Checked on liferx.md

    Top dose: same price at 15 mg

    Terms & source

    Advertised price: "Compounded tirzepatide is $197 and compounded semaglutide is $147 per month, at every dose."; the plan card says "Same price at every dose", "Your price stays the same as your dose changes" and "No auto-billing"

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Top-dose terms: The seller states one price at every dose, so this is also its price at 15 mg.

    Refills are requested when you are ready ("We never auto-bill."). Pricing, eligibility and other terms apply per the page. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (liferx.md)
  • View
    $199/mo (glp1.medvi.org)

    Checked on glp1.medvi.org

    Top dose: No separate price on record

    Terms & source

    Advertised price: refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

    Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (glp1.medvi.org)
  • View
    $299/mo (glp1.medvi.org/results/cv-tirz)

    ≈ $320.36 per 30 days

    Checked on glp1.medvi.org

    Top dose: same price at 15 mg

    Terms & source

    Advertised price: monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    28-day supply (glp1.medvi.org)

    ≈ $320.36 per 30 days at this quoted rate

    Other plan lengths

    • $193/mo on 3 months
    • $183/mo on 6 months
    • $166/mo on 12 months

    Top-dose terms: The seller states one price at every dose, so this is also its price at 15 mg.

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (glp1.medvi.org)

Read prices in context. Compare the same product, dose and payment terms; missing prices are not estimated. Compounded medicines are not FDA-approved.

How this list is ordered. Some sellers may pay us a referral fee, as their terms say. In this sort they are not moved up, and it never changes what you pay.

How prices are compared, what FDA says about compounding and how we earn

A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes, converted to 30 days: by the supply a price buys where the seller states it in days, otherwise a monthly price with its plan length on record read as four weekly doses, a yearly membership in the price spread over twelve months. Introductory prices, ranges, prices with no plan length on record and separately billed fees are unranked references. Dose changes and added fees affect what you pay.

A listed maintenance dose is not a dosing recommendation.

FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize). Its conditions for a pharmacy compounding them now include "The drug product is compounded for an individual patient based on receipt of a prescription" and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) In May 2026 FDA proposed leaving semaglutide, tirzepatide and liraglutide off the 503B Bulks List (federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal), the ingredients outsourcing facilities may compound from; comments closed Jul 30, 2026 (govinfo.gov/content/pkg/FR-2026-06-26/html/2026-12937.htm), and we found no final notice when we last read the Federal Register (Nov 6, 2026). FDA's newest warning letter to a pharmacy over compounded semaglutide or tirzepatide went to Empower Clinic Services, LLC dba Empower Pharmacy (fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026) on Sep 18, 2026 (every GLP-1 warning letter). FDA's newest recall report of a compounded semaglutide or tirzepatide product is Houston Rx LLC's tirzepatide (api.fda.gov/drug/enforcement.json), reported Oct 21, 2026: "Lack of assurance of sterility." (every tirzepatide recall). Liraglutide is different: FDA's shortage database (accessdata.fda.gov/scripts/drugshortages) still lists it in shortage (updated at source Oct 14, 2026; every GLP-1 shortage). FDA: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." (fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) A low price is not a low-risk signal; confirm current terms with the provider.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

Public record

LifeRx.md vs MEDVi: reviews, BBB and FDA

What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.

LifeRx.md

Trustpilot 4.8 from 5,677 reviews. The BBB's search lists a business named LifeRx, MD Inc in Cherry Hill, NJ under health and wellness, rated A+ (bbb.org/us/nj/cherry-hill/profile/health-and-wellness/liferx-md-inc-0221-90211690, read Nov 14, 2026). A search result does not say which website a business runs, so we have not matched it to LifeRx.md's site. We found no FDA warning letter naming LifeRx.md as of Nov 15, 2026.

Is LifeRx.md legit?

MEDVi

Trustpilot 4.3 from 15,227 reviews. The BBB rates MEDVi F, with 789 complaints filed in the last 3 years. It is not BBB accredited. The FDA sent MEDVi a warning letter (Feb 20, 2026) about claims on its website. The words that letter quotes ("Same active ingredient as Wegovy® and Ozempic®") were on none of the 3 pages of home.medvi.org and glp1.medvi.org we read on Nov 16, 2026.

Is MEDVi legit?

Seller pages re-read automatically : 3 of 3 opened and checked for price changes. How prices stay current

Updated automatically

LifeRx.md and MEDVi price changes

  • Seller recordMEDVi: updated record on its public ratings and records
  • Seller recordLifeRx.md: new record on its public ratings and records
  • Seller recordLifeRx.md: updated record on its public ratings and records
  • PriceMEDVi: Compounded tirzepatide via MEDVi now ranked per 30 days at about $320: $299/mo buys 28 days (read on glp1.medvi.org)
  • Seller recordMEDVi: updated record on who makes its medicine (read on home.medvi.org)
  • PriceMEDVi: Compounded semaglutide via MEDVi now $199/mo (was $299/mo) (read on glp1.medvi.org)

Written from each source's own record as it changes. Every change on GLPcompare

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.